Conference
Tuesday, June 3, 2008
9:00 A.M. - 4 P.M.
| Session 203 - Product Innovation and Development |
Chair: Sharad Rastogi, Principal, Life Sciences Business Group, PRTM; and Tim Durst, Director, Life Sciences, PRTM
Industry Panelists: Izi Bruker, VP, R&D, J&J DePuy Mitek; Andrew Lichkus, Ph.D, VP and CTO, DENTSPLY International; Joe Alampi, VP, Program Management and IT Respironics; Boris Leschinsky, VP, Technology, Datascope Corp.; and Mary Hayes, PhD., Sr. Director, Program Management, Siemens Healthcare Diagnostics Inc.
Part I: Emerging Strategies in Product Development
Introduction to Emerging Strategies and Management Levers
- Gaining advantage through technology strategy and management
- Balancing investments with portfolio strategy
- Open Innovation: New models and emerging practices for collaboration
- Developing and optimizing global R&D centers
- Driving growth through total customer solutions
- Platform Strategies: Driving growth and leverage
Panel Discussion with Medical Manufacturing Executives
Part II: The Concept to Launch Cycle: Methods and Tools for Effective Execution
- Transforming product innovation and development capabilities
- Voice of the customer
- Product lifecycle management systems and tools
Panel Discussion with Medical Manufacturing Executives |

ABOUT THE INSTRUCTORS
Sharad Rastogi, Principal, Life Sciences Business Group, PRTM
Sharad Rastogi is a Principal in the Life Sciences and Healthcare practice of PRTM Management Consultants. He has advised a range of small, mid-size, and large life sciences companies on operational strategies and execution to drive growth and improve profitability. He has extensive experience in market and product strategic planning; innovation and product development management; portfolio, project and resource management; alliance management; technology and intellectual property management; and product lifecycle management. He has led transformational initiatives at several clients to make high impact and lasting performance improvements in these areas. Sharad has over 17 years of professional experience, an MBA from the Wharton School of the University of Pennsylvania, an MS from Ohio State University, and a Bachelor of Technology degree from the Indian Institute of Technology.
Tim Durst, Director, Life Sciences, PRTM
Tim Durst is a Partner in PRTM, a global management consulting firm that specializes in business innovation. He is part of PRTM’s Life Science Business Group and focuses on medical device, diagnostics, and supplies industries and has 20 years of expertise in business strategy, operational transformation, and innovation.
Tim has helped many Fortune 500 companies, including many top-tier medical companies, drive step improvements in business performance. He is a thought-leader in total solution innovation and has led multiple engagements to improve innovation capabilities; including establishing best-in-class practices in strategy, portfolio and platform management, product development, licensing and collaboration, and technology management. This has resulted in more innovative products, improved investment optimization, significant cycle-time and productivity improvements, and increased market share for his clients.
Prior to PRTM, Tim worked in management and engineering roles at 3M Company, A.O. Smith, and Rockwell. Tim has a Master of Business Administration from the University of Chicago and holds a Bachelor of Science in Electrical Engineering from GMI Engineering and Management Institute (Kettering). ABOUT THE PANELISTS
Izi Bruker, VP, R&D, J&J DePuy Mitek
Izi Bruker, Ph.D., is Vice President of Global R&D for Depuy Mitek- Johnson and Johnson. Prior to his current role at Depuy Mitek, Dr. Bruker worked as Manager of Polymer Process Group for GE Corporate R&D and later became Director of R&D for Ethicon-Johnson and Johnson. His professional interests consist of device, drug/device, and tissue engineering R&D for medical device development in the area of sports medicine and arthroscopy. Dr. Izi Bruker has a Ph.D. in Chemical Engineering from the University of Wisconsin and holds a Bachelor of Science degree in Chemical Engineering from Rensselaer Polytechnic Institute.
Andrew Lichkus, Ph.D, VP and CTO, DENTSPLY International
In his position as Vice President and Chief Technology Officer, Dr. Lichkus is responsible for worldwide product development for Dentsply International. He has been a successful contributor in medical and dental device development for nearly two decades. He has recently directed research and development in a wide range of dental applications including dental diagnostic devices, fixed and removable prostheses, as well as restorative products, orthodontic and endodontic devices. His early work focused on the development of bioresorbable materials useful in the design and manufacture of wound closure devices such as sutures, ligating clips and tissue adhesives. Dr. Lichkus holds several patents relating to medical and dental devices. He is a member of the American Chemical Society, the American Institute of Chemical Engineers, as well as the International and American Associations of Dental Research. He received his undergraduate degree in Chemical Engineering from University of Natal, South Africa and post-graduate degrees from University of Natal (MSc Chemical Engineering) and Pennsylvania State University (Ph.D. Polymer Science).
Joe Alampi, VP, Program Management and IT Respironics
Mr. Alampi is currently a Vice President with Respironics, responsible for Program Management and Information Technology. Mr. Alampi has recently been given responsibility for leading the post acquisition integration following the acquisition of Respironics by Philips. Mr. Alampi joined Respironics in October 2005 and was charged with improving the results of the company’s New Product Development efforts. In mid-2006 he was given the responsibility to lead and manage Information Technology for Respironics’ Sleep and Home Respiratory Group.
At Respironics, Mr. Alampi has led cross-functional teams in defining, developing and implementing a New Product Commercialization process built upon strong Stage-Gate and Project Management processes, as well as key performance indicators.
Prior to joining Respironics, Mr. Alampi worked for General Motors as Director, Process Engineering for the functional areas of Manufacturing, Quality and Supply Chain. In this role Mr. Alampi was charged with identifying and developing leading business practices and process improvements in support of GM’s strategies. Previously Mr. Alampi was a Senior Manager within the Automotive Strategy and Operations Consulting Practice of Deloitte Consulting in Detroit, with responsibility for leading solution development and implementation for large OEM and supplier clients. Prior to joining Deloitte he was a Financial Controller with BMW AG in Munich, Germany and held positions of increasing responsibility with Unova/Lamb Technicon.
Mr. Alampi possesses eighteen years of diverse operations, management and information technology experience. He has extensive experience in manufacturing management, lean manufacturing, assembly process management, supply chain and supplier management and information technology strategy development, technology selection and technology implementation. Mr. Alampi holds an International Master of Business Administration degree in Finance and Operations from the University of South Carolina and a Bachelor of Science degree in Industrial Engineering from Kettering University.
Boris Leschinsky, VP, Technology, Datascope Corp.
Mr. Leschinsky has worked for over 20 years developing medical devices, in particular cardiac assist technology including artificial heart, left-ventricular assist devices and various blood pumps as well as intra-aortic balloon pumps. He is a named inventor on over 30 US and many international patents. Recently he was nominated for a 2008 Inventor of the Year Award by the New York Intellectual Property Lawyers Association for his lifetime achievements in advancing medical technology.
Mary Hayes, PhD., Sr. Director, Program Management, Siemens Healthcare Diagnostics Inc.
In her role as Head of the Program Management Office (PMO) at Siemens Healthcare Diagnostics, Dr. Hayes is responsible for defining and implementing processes and practices for management of the company’s new product development programs. A key PMO objective is enabling the success of project managers by providing the expertise, knowledge and guidance that facilitates a globally consistent new product development process from research through commercialization. During the last year, Dr. Hayes led a cross-functional, company-wide integration project that harmonized multiple legacy product development practices to a common single process aligned with the Siemens Healthcare product development standards. Her experience includes senior management roles in R&D, Operations and Service for both start up and large multi-national life sciences and medical diagnostics companies. She holds a Ph.D. in Biochemistry from Tufts University. |